Both in Pharmaceuticals
Enliven Therapeutics vs Acadia Pharmaceuticals
Over the past year ELVN returned +148.6% and ACAD returned −1.7%; their daily moves had a correlation of 0.20.
ELVN +148.6% ACAD −1.7%Growth of $1, one year, split-adjusted
| Metric | ELVN | ACAD |
|---|---|---|
| Price | $47.25 | $21.47 |
| Market cap | $3.46B | $3.70B |
| Today | +5.40% | +4.38% |
| 1 month | +11.5% | +8.8% |
| 6 months | +14.7% | 0.0% |
| Year to date | +206.8% | −19.6% |
| 1 year | +136.3% | −4.0% |
| Revenue growth (YoY) | — | +16.4% |
| Gross margin | — | 90.8% |
| Net margin | — | 10.2% |
| P/E (TTM) | — | 9.7× |
| Price / sales | — | 3.2× |
| Net cash | $895.2M | $956.5M |
| Dividend yield | — | — |
| Volatility (60d) | 41.7% | 44.9% |
| Short % of float | 16.4% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).